According to Aldeyra Therapeutics
's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 4.14 | 140.39% |
2023-12-31 | 1.72 | -36.14% |
2022-12-31 | 2.70 | 138.97% |
2021-12-31 | 1.13 | -74.76% |
2020-12-31 | 4.48 | 29.24% |
2019-12-31 | 3.46 | 37.69% |
2018-12-31 | 2.51 | -23.39% |
2017-12-31 | 3.28 | 5.63% |
2016-12-31 | 3.11 | 17.41% |
2015-12-31 | 2.65 | -58.61% |
2014-12-31 | 6.39 | |
2013-12-31 | N/A | |
2012-12-31 | N/A |